news and presentations

Press releases

Rapport Therapeutics Appoints Terry-Ann Burrell to Board of Directors

BOSTON, Mass. and SAN DIEGO, Calif. – January 16, 2024 – Rapport Therapeutics, Inc., a clinical-stage biotechnology company leveraging the…

Read Rapport Therapeutics Appoints Terry-Ann Burrell to Board of Directors Now
Rapport Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference

BOSTON, Mass. and SAN DIEGO, Calif. – January 3, 2024 – Rapport Therapeutics, Inc., a clinical-stage biotechnology company leveraging the…

Read Rapport Therapeutics Appoints Terry-Ann Burrell to Board of Directors Now
Rapport Therapeutics Appoints Chief Financial Officer

BOSTON and SAN DIEGO – October 30, 2023 – Rapport Therapeutics, Inc., a clinical-stage biotechnology company leveraging the science of receptor-associated…

Read Rapport Therapeutics Appoints Terry-Ann Burrell to Board of Directors Now
Rapport Therapeutics Appoints Chief Operating Officer and Scientific Advisory Board Member

BOSTON and SAN DIEGO – September 7, 2023 – Rapport Therapeutics, Inc., a clinical-stage biotechnology company leveraging the science of…

Read Rapport Therapeutics Appoints Terry-Ann Burrell to Board of Directors Now
Rapport Therapeutics Raises $150 Million in Series B Funding Round and Announces Key Board Appointments to Further Advance Precision Neuromedicine Platform

Funding to support ongoing clinical programs in seizure and psychiatric disorders and precision neuromedicine discovery platform Raymond Kelleher, M.D., Ph.D.,…

Read Rapport Therapeutics Appoints Terry-Ann Burrell to Board of Directors Now
Rapport Therapeutics Names Scientific Advisory Board

Board to be co-chaired by two Nobel laureates Members include world-renowned experts in ion channel signaling, seizure disorders and the…

Read Rapport Therapeutics Appoints Terry-Ann Burrell to Board of Directors Now
Rapport Therapeutics Launches with $100 Million to Transform the Treatment of Neurological Disease through the Discovery and Development of Precision Therapies

Series A financing led by Third Rock Ventures with participation from ARCH Venture Partners and Johnson & Johnson Innovation-JJDC, Inc….

Read Rapport Therapeutics Appoints Terry-Ann Burrell to Board of Directors Now